Nesvacumab
Sign in to saveNesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2. , the drug was in Phase II clinical trials for the treatment of diabetic macular edema.
Wikidata facts
- Subclass of
- chemical compound
Show 1 more fact
- subject has role
- monoclonal antibody
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Nesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2. , the drug was in Phase II clinical trials for the treatment of diabetic macular edema.
This drug is being developed by Regeneron Pharmaceuticals.
Excerpted from Wikipedia’s “Nesvacumab” article, available under the CC BY-SA 4.0 licence.